The Hertford British Hospital was a hospital founded in Paris in 1871 for British and other English-speaking patients. In 2008 it merged with a nearby French hospital and was renamed to Hôpital franco-britannique.

During the past decade, Institut Hospitalier Franco-Britannique; Cancerologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut Hospitalier Franco-Britannique; Cancerologie" are "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials), "Colorectal Cancer" (1 trials), "Solid Tumours" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Institut Hospitalier Franco-Britannique; Cancerologie" in a lesser frequency.

Most popular intervention types in "Institut Hospitalier Franco-Britannique; Cancerologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Nab-Paclitaxel" (2 trials), "5-FU/LV" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Hospitalier Franco-Britannique; Cancerologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Institut Hospitalier Franco-Britannique; Cancerologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut Hospitalier Franco-Britannique; Cancerologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Hospitalier Franco-Britannique; Cancerologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".